Business
Imagion (ASX:IBX) share price up 1,166% in a year pursuing ‘radiation-free’ cancer tech
The Imagion Biosystems Ltd (ASX: IBX) share price has rocketed 1,166% over the past 12 months due to a series of promising projects around cancer detection.
The company’s bio is truly a mouthful: its principal business activities consist of nanotechnology, biotechnology, cancer diagnostics, and – the clincher — superparamagnetic relaxometry.
What investors should know is that it develops medical devices focused around cancer screening technology.
Imagion’s Magsense cancer screening technology
One of these tech projects, called Magsense, is a diagnostic imaging tool that can potentially increase…
-
Noosa News19 hours agoPrincess Anne is coming to Australia. Here’s what we know of her plans
-
General8 hours agoCommunity devastated after freight train kills one-year-old girl near Narrabri
-
General6 hours agoPolice allowed neo-Nazi protest outside NSW parliament
-
General22 hours agoTravellers face cancelled flights over US shutdown